Cited by 505Inflammatory Bowel DiseaseSmoking Behavior and CessationMicroscopic Colitis

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Transdermal Nicotine for Active Ulcerative Colitis

Pullan, Rupert D., Rhodes, John, Ganesh, Subramanian, Mani, Venk, Morris, John S., Williams, Geraint T., Newcombe, Robert G., Russell, Michael, Feyerabend, Colin, Thomas, Gareth, Sawe, Urbain·1994·New England Journal of Medicine

DOI 10.1056/nejm199403243301202

Open this paper in CoChat — free account

Abstract

BACKGROUND: Ulcerative colitis is largely a disease of nonsmokers. Because anecdotal reports suggest that smoking and nicotine may improve the symptoms of the disease, we examined the effect of nicotine as a supplemental treatment for ulcerative colitis. METHODS: We treated 72 patients with active ulcerative colitis with either transdermal nicotine patches or placebo patches for six weeks in a randomized, double-blind study. Incremental doses of nicotine were given; most patients tolerated doses of 15 to 25 mg per 24 hours. All the patients had been taking mesalamine, and 12 were receiving low doses of glucocorticoids; these medications were continued without change during the study. Clinical, sigmoidoscopic, and histologic assessments were made at base line and at the end of the study; symptoms were recorded daily on a diary card, and the clinician made a global assessment. Side effects and plasma nicotine and cotinine concentrations were monitored throughout the study. RESULTS: Seventeen of the 35 patients in the nicotine group had complete remissions, as compared with 9 of the 37 patients in the placebo group (P = 0.03). The patients in the nicotine group had greater improvement in the global clinical grade of colitis (P < 0.001) and the histologic grade (P = 0.03), lower stool frequency (a difference of 1.6 stools daily; P = 0.008), less abdominal pain (P = 0.05), and less fecal urgency (P = 0.009). More patients in the nicotine group had side effects (23, vs. 11 in the placebo group; P = 0.002), the most common of which were nausea, lightheadedness, headache, and sleep disturbance. Withdrawals due to ineffective therapy were more common in the placebo group (3 vs. 8, P = 0.12). CONCLUSIONS: The addition of transdermal nicotine to conventional maintenance therapy improves symptoms in patients with ulcerative colitis.

Integrity signals

Registry

Crossref · 10.1056/nejm199403243301202

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistical Methods for Rates and Proportions, 2nd ed
GROVE, W. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1644-a · Cited by 3,756
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,793
Comparison of tests used to distinguish smokers from nonsmokers
Jarvis, M. J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., & Saloojee, Y. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.11.1435 · Cited by 994
Self-citation
Variation Between Observers in Describing Mucosal Appearances in Proctocolitis
Baron, J. H., Connell, A. M., & Lennard‐Jones, J. E. (1964) · BMJ · doi:10.1136/bmj.1.5375.89 · Cited by 607
Daily intake of nicotine during cigarette smoking
Benowitz, N. L., & Jacob, P. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.67 · Cited by 502
Biopsy Studies in Ulcerative Colitis
Truelove, S. C., & Richards, W. C. D. (1956) · BMJ · doi:10.1136/bmj.1.4979.1315 · Cited by 394
Non-smoking: a feature of ulcerative colitis.
Harries, A. D., Baird, A., & Rhodes, J. (1982) · BMJ · doi:10.1136/bmj.284.6317.706 · Cited by 328
Self-citation
A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids
Feyerabend, C., & Russell, M. A. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb06592.x · Cited by 309
Self-citation
A Double-Blind Trial of a 16-Hour Transdermal Nicotine Patch in Smoking Cessation
Tønnesen, P., Nørregaard, J., Simonsen, K., & Säwe, U. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250503 · Cited by 296
Cigarette Smoking: A Dependence on High-Nicotine Boli
Russell, M. A. H., & Feyerabend, C. (1978) · Drug Metabolism Reviews · doi:10.3109/03602537808993776 · Cited by 253
Self-citation

Show all 28 references

Research works printed but not linked: 6

Roberts CJ, 1982, BMJ, 285, 440
Srivastava ED, 1991, Eur J Gastroenterol, 3, 815
Allen A, Bell A, McQueen S. Mucus and mucosal protection. In: Allen A, Flemstrom G, Garner A, Silen W, Turnberg LA, eds. Mechanisms of mucosal protection in the upper gastrointestinal tract. New York: Raven Press, 1984:195-201.
Cope GF, 1986, Gut, 27, A618
Dubois JP, 1989, Methods Find Exp Clin Pharmacol, 11, 187
Russell MAH. Nicotine intake and its control over smoking. In: Wonnacott S, Russell MAH, Stolerman IP, eds. Nicotine psychopharmacology: molecular, cellular, and behavioural aspects. Oxford, England: Oxford University Press, 1990:374-418.

Sorted by citations

Items 201–300 of 505

Metabolism and biochemical effects of nicotine for primary care providers
Metz, C. N., Gregersen, P. K., & Malhotra, A. K. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.06.004 · Cited by 37
“Most subjects refractory to standard therapies with mildmoderate clinical relapses of ulcerative colitis treated with nicotine (patch or enema) showed clinical improvement with transient and mild adverse effects [95–98].”
Background
Effect of Nicotine on Immune System Function
Mahmoudzadeh, L., Froushani, S. M. A., Ajami, M., & Mahmoudzadeh, M. (2022) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.008 · Cited by 45
“3% experienced side effects.(77) Followed in 1997, and the results indicated that although nicotine reduces the symptoms of UC, it is not significantly different from standard immunosuppressive treatments for the disease,(78) hence, the use of nicotine in the treatment of UC is doomed to failure.”
Result
Different pharmacokinetics of nicotine following intravenous administration of nicotine base and nicotine hydrogen tartarate in rats
Jung, B. H., Chung, B. C., Chung, S., & Shim, C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00452-7 · Cited by 37
Development of a rectal nicotine delivery system for the treatment of ulcerative colitis
Dash, A. K., Gong, Z., Miller, D. W., Huai‐Yan, H., & Laforet, J.-P. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00221-5 · Cited by 37
No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study
Vleggaar, F. P., van Buuren, H. R., Henegouwen, G. P. V. B., Hop, W. C. J., & van Erpecum, K. J. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200102000-00013 · Cited by 37
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2)
Kucharzik, T., Dignass, A., Atreya, R., Bokemeyer, B., Esters, P., Herrlinger, K., Kannengiesser, K., Kienle, P., Langhorst, J., Lügering, A., et al. (2024) · Zeitschrift für Gastroenterologie - German Journal of Gastroenterology · doi:10.1055/a-2271-0994 · Cited by 37
Biological effects of nicotine exposure: A narrative review of the scientific literature
Price, L., & Martinez, J. (2019) · F1000Research · doi:10.12688/f1000research.20062.1 · Cited by 55
Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats
Eliakim, R., Karmeli, F., Cohen, P., Heyman, S. N., & Rachmilewitz, D. (2001) · International Journal of Colorectal Disease · doi:10.1007/s003840000262 · Cited by 36
“Nicotine patches have also been shown to ameliorate active UC in a well designed, controlled double-blind placebo study [4].”
Background
Evolving Treatment Strategies for Inflammatory Bowel Disease
Hanauer, S. B., & Dassopoulos, T. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.299 · Cited by 36
Clinical and histological characterization of oral pemphigus lesions in patients with skin diseases: a cross sectional study from Sudan
Suliman, N. M., Åstrøm, A. N., Ali, R. W., Salman, H., & Johannessen, A. C. (2013) · BMC Oral Health · doi:10.1186/1472-6831-13-66 · Cited by 35
“Although it is considered one of the leading morbidity and mortality risk factors [68], some clinical evidence has supported its beneficial and protective effect on patients with pemphigus [69] and certain diseases such as ulcerative colitis and recurrent aphthous ulcers [70,71].”
Background
Immunohistochemistry of the B‐Cell Component in Lower Lip Salivary Glands of Sjögren's Syndrome and Healthy Subjects
Larsson, Å., Bredberg, A. C. A., Henriksson, G., Manthorpe, R., & Sallmyr, A. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2005.01540.x · Cited by 35
“This may be due to an anti-inflammatory effect of nicotin [12] likely mediated via a nicotinic acetylcholine receptor [13].”
Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease
Coruzzi, P., Castiglioni, P., Parati, G., Brambilla, V., Brambilla, L., Gualerzi, M., Cademartiri, F., Franzè, A., Angelis, G. D., Rienzo, M. D., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01887.x · Cited by 35
Active and passive smoking and risk of ovarian cancer
Baker, J. A., Odunuga, O. O., Rodabaugh, K. J., Reid, M. E., Menezes, R. J., & Moysich, K. B. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00473.x · Cited by 34
Prolonged delivery of nicotine in rats via nasal administration of proliposomes
Jung, B. H., Chung, B. C., Chung, S., Lee, M.-H., & Shim, C. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00258-8 · Cited by 34
Does nicotine have beneficial effects in the treatment of certain diseases?
Birtwistle, J., & Hall, K. (1996) · British Journal of Nursing · doi:10.12968/bjon.1996.5.19.1195 · Cited by 34
Anti-Inflammatory Effects of the Nicotinergic Peptides SLURP-1 and SLURP-2 on Human Intestinal Epithelial Cells and Immunocytes
Chernyavsky, A. I., Galitovskiy, V., Shchepotin, I. B., & Grando, S. A. (2014) · BioMed Research International · doi:10.1155/2014/609086 · Cited by 33
Primary sclerosing cholangitis: Updates in diagnosis and therapy
Portincasa, P. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i1.7 · Cited by 33
NOVEL THERAPIES FOR INFLAMMATORY BOWEL DISEASE
Sands, B. E. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70059-5 · Cited by 33
Smoking, disease activity, permanent damage and dsDNA autoantibody production in patients with systemic lupus erythematosus
Ekblom-Kullberg, S., Kautiainen, H., Alha, P., Leirisalo‐Repo, M., Miettinen, A., & Julkunen, H. A. (2013) · Rheumatology International · doi:10.1007/s00296-013-2889-7 · Cited by 32
Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study
Guslandi, M. (1999) · International Journal of Colorectal Disease · doi:10.1007/s003840050221 · Cited by 32
“The apparently favorable effect of cigarette smoking on the course of ulcerative colitis has been ascribed to nicotine, and indeed controlled studies have shown that transdermal nicotine, when added to standard mesalazine treatment, is significantly effective in inducing clinical benefit in ulcerative colitis patients…”
Background
Does nicotine influence cytokine profile and subsequent cell cycling/apoptotic responses in inflammatory bowel disease?
Aldhous, M. C., Prescott, R. J., Roberts, S. B., Samuel, K., Waterfall, M., & Satsangi, J. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20523 · Cited by 32
Is Transdermal Nicotine Associated with Cardiovascular Risk?
Thomas, G. A. O., Davies, S., Rhodes, J., Russell, M. A., Feyerabend, C., & Säwe, U. (1995) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)00537-9 · Cited by 32
Self-citation
Pathophysiology of Inflammatory Bowel Diseases
Chen, C.-J., Hu, H., & Liao, W.-T. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2101562 · Cited by 32
Identifying, Understanding, and Managing Fecal Urgency in Inflammatory Bowel Diseases
Caron, B., Ghosh, S. K., Danese, S., & Peyrin‐Biroulet, L. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.02.029 · Cited by 32
Inflammatory bowel disease: sorting out the treatment options.
Wolf, J. M., & Lashner, B. A. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.8.621 · Cited by 31
Nicotine for Pyoderma Gangrenosum
Wolf, R., & Ruocco, V. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.9.1071 · Cited by 31
“This result has also been confirmed in a recent double-blind, controlled trial with transdermal nicotine patches.(3) Pyoderma gangrenosum is well known to be associated with ulcerative colitis.”
Result
Noradrenergic and cholinergic neural pathways mediate stress-induced reactivation of colitis in the rat
Saunders, P. R., Miceli, P. C., Vallance, B. A., Wang, L., Pinto, S., Tougas, G. H., Kamath, M., & Jacobson, K. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2005.12.002 · Cited by 31
Nicotine stereoisomers and cotinine stimulate prostaglandin E2 but inhibit thromboxane B2 and leukotriene E4 synthesis in whole blood
Saareks, V., Mucha, I., Sievi, E., Vapaatalo, H., & Riutta, A. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00384-7 · Cited by 31
Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitis (UC)
Louvet, B., Buisine, M., Desreumaux, P., Tremaine, W., Aubert, J., Porchet, N., Colombel, J. F., & Sandborn, W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)84182-6 · Cited by 31
From Neuroimunomodulation to Bioelectronic Treatment of Rheumatoid Arthritis
Kanashiro, A., Bassi, G. S., Cunha, F. Q., & Ulloa, L. (2018) · Bioelectronics in Medicine · doi:10.2217/bem-2018-0001 · Cited by 34
“Actually, cholinergic agonists such as nicotine have been previously used in clinical trials to control inflammation in ulcerative colitis [67].”
Background
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009
Kucharzik, T., Dignass, A., Atreya, R., Bokemeyer, B., Esters, P., Herrlinger, K., Kannengiesser, K., Kienle, P., Langhorst, J., Lügering, A., et al. (2023) · Zeitschrift für Gastroenterologie - German Journal of Gastroenterology · doi:10.1055/a-2060-0935 · Cited by 24
Nicotinic Acetylcholine Receptor Expression and Susceptibility to Cholinergic Immunomodulation in Human Monocytes of Smoking Individuals
van der Zanden, E. P., Hilbers, F. W., Verseijden, C., van den Wijngaard, R. M., Skynner, M., Lee, K., Ulloa, L., Boeckxstaens, G. E., & de Jonge, W. J. (2012) · NeuroImmunoModulation · doi:10.1159/000335185 · Cited by 30
Systems biology approach highlights mechanistic differences between Crohn’s disease and ulcerative colitis
Ruiz, P. A., Yepiskoposyan, H., Gubian, S., Calvino-Martin, F., Kogel, U., Renggli, K., Peitsch, M. C., Hoeng, J., & Talikka, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-91124-3 · Cited by 29
Activation of the alpha-7 nicotinic acetylcholine receptor (α7 nAchR) reverses referred mechanical hyperalgesia induced by colonic inflammation in mice
da Costa, R., Motta, E. M., Manjavachi, M. N., Cola, M., & Calixto, J. Β. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.004 · Cited by 29
Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease
Zanussi, J., Zhao, J., Wei, W., Karakoc, G., Chung, C. P., Feng, Q., Olsen, N. J., Stein, C. M., & Kawai, V. K. (2023) · BMC Rheumatology · doi:10.1186/s41927-023-00349-4 · Cited by 31
“In animal models, nicotine dampens the inflammatory response [48], and administration of nicotine reduced inflammation [49] in patients with ulcerative colitis [50], and lupus [48].”
Background
Pilot trial of nicotine patches as an alternative to corticosteroids in ulcerative colitis
Guslandi, M., & Tittobello, A. (1996) · Journal of Gastroenterology · doi:10.1007/bf02355071 · Cited by 28
Promising New Agents for the Treatment of Inflammatory Bowel Disorders
Lang, K. A., & Peppercorn, M. A. (1999) · Drugs in R&D · doi:10.2165/00126839-199901030-00011 · Cited by 28
“[36,37] Overall, transdermal nicotine appears to be of modest benefit for patients with active disease, yet is less effective than prednisolone 15mg daily.”
Background
Nicotine treatment ameliorates DSS-induced colitis by suppressing MAdCAM-1 expression and leukocyte recruitment
Maruta, K., Watanabe, C., Hozumi, H., Kurihara, C., Furuhashi, H., Takajo, T., Okada, Y., Shirakabe, K., Higashiyama, M., Komoto, S., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0717-304r · Cited by 27
Neural Regulation of Interactions Between Group 2 Innate Lymphoid Cells and Pulmonary Immune Cells
Chen, W., Shu, Q., & Fan, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576929 · Cited by 28
A dose‐ranging pharmacokinetic study of nicotine tartrate following single‐dose delayed‐release oral and intravenous administration
COMPTON, R. F., Sandborn, W. J., LAWSON, G. M., SHEETS, A. J., Mays, D. C., Zins, B., Tremaine, W. J., Lipsky, J. J., Mahoney, D. W., Zinsmeister, A. R., et al. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00236.x · Cited by 27
Effects of transdermal nicotine on lower esophageal sphincter and esophageal motility
Kadakia, S. C., la Baume, H. R. D., & Shaffer, R. T. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02071391 · Cited by 26
“This high incidence of side effects in our study is similar to the 66% (23 of 35 patients) incidence noted by Pullan et al using a 15-mg transdermal nicotine patch (same strength as in our study) for the treatment of active ulcerative colitis ( 21 ).”
ResultInfluential
Nicotine for pyoderma gangrenosum
Kanekura, T., Usuki, K., & Kanzaki, T. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90802-1 · Cited by 26
Review article: Refractory distal colitis—explanations and options
Griffin, M. G., & Miner, P. B. (1996) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1996.tb00175.x · Cited by 25
Cholinergic immunomodulation in inflammatory bowel diseases
Serafini, M. A., Paz, A. H. D. R., & Nunes, N. S. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100401 · Cited by 27
In vivo Influence of Nicotine on Human Basal and NSAID-induced Gut Barrier Function
Suenaert, P., Bulteel, V., Hond, E. D., Geypens, B. J., Monsuur, F., Luypaerts, A., Ghoos, Y. F., & Rutgeerts, P. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310000834 · Cited by 25
Pharmacokinetics of nicotine carbomer enemas: A new treatment modality for ulcerative colitis
Green, J. T., Thomas, G. A. O., Rhodes, J., Evans, B. K., Russell, M. A. H., Feyerabend, C., Fuller, G. S., Newcombe, R. G., & Sandborn, W. J. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90167-3 · Cited by 25
Self-citation
Vagal stimulation ameliorates murine colitis by regulating SUMOylation
Youssef, A., Rehman, A. U., Elebasy, M., Roper, J., Sheikh, S. Z., Karhausen, J., Yang, W., & Ulloa, L. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adl2184 · Cited by 24
Evaluating oral noncombustible potential-reduced exposure products for smokers
Blank, M. D., & Eissenberg, T. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq003 · Cited by 24
Measures for Assessing Subjective Effects of Potential Reduced-Exposure Products
Hanson, K. L., O’Connor, R. J., & Hatsukami, D. K. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0971 · Cited by 24
“Scales and items used to measure subjective responses to PREPs Scale Cancer Epide Studies that used the scale miol Biomarkers Prev 2009;18(12 Items Withdrawal symptoms and craving scales The Minnesota Nicotine Withdrawal Scale (7) X (8) Items were rated as 0, not present; 1, slight; 2, mild, 3, moderate; or 4, severe,…”
BackgroundInfluential
Poor Tolerability of a Transdermal Nicotine Treatment in Parkinson's Disease
Lemay, S., Blanchet, P. J., Chouinard, S., Masson, H., Soland, V., & Bédard, M. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200309000-00004 · Cited by 24
Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine
Ingram, J. R., Routledge, P. A., Rhodes, J., Marshall, R. W., Buss, D. C., Evans, B. K., Feyerabend, C., & Thomas, G. A. O. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02199.x · Cited by 24
Self-citation
Nicotine in Ulcerative Colitis
Cohen, R. D., & Hanauer, S. B. (1996) · BioDrugs · doi:10.1007/bf03259080 · Cited by 24
Consumo de tabaco. Efeitos na saúde.
Nunes, E. D. S. (2006) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v22i2.10231 · Cited by 26
Acetylcholine-producing T cells augment innate immune-driven colitis but are redundant in T cell-driven colitis
Willemze, R. A., Brinkman, D. J., Welting, O., van Hamersveld, P. H. P., Verseijden, C., Luyer, M. D. P., Wildenberg, M. E., Seppen, J., & de Jonge, W. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00067.2019 · Cited by 23
Preliminary Observations of Oral Nicotine Therapy for Inflammatory Bowel Disease: An Open-Label Phase I-Ii Study of Tolerance
Ingram, J. R., Rhodes, J., Evans, B. K., & Thomas, G. A. O. (2005) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780111209 · Cited by 23
Self-citation
The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease
Sher, M. E., Bank, S., Greenberg, R., Sardinha, T. C., Weissman, S., Bailey, B., Gilliland, R., & Wexner, S. D. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780050202 · Cited by 23
Inflammatory bowel disease
Moses, P. L., Moore, B. R., Ferrentino, N., Bensen, S. P., & Vecchio, J. A. (1998) · Postgraduate Medicine · doi:10.3810/pgm.1998.05.483 · Cited by 23
An Official American Thoracic Society Research Statement: Current Understanding and Future Research Needs in Tobacco Control and Treatment
Leone, F. T., Carlsen, K., Folan, P. A., Latzka, K., Munzer, A., Neptune, E., Pakhale, S. S., Sachs, D. P. L., Samet, J. M., Upson, D. J., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1081st · Cited by 23
“Nicotine relieves nicotine withdrawal symptoms in abstaining smokers, improves cognitive function in nonsmoking adults (178), and appears to have therapeutic effects in neurodegenerative diseases (179, 180), attention disorders (181), and inflammatory bowel disease (182, 183).”
Background
Interventions for the management of abdominal pain in ulcerative colitis
Sinopoulou, V., Gordon, M. A., Dovey, T. M., & Akobeng, A. K. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013589.pub2 · Cited by 21
Divergent Effect of Cigarette Smoke on Innate Immunity in Inflammatory Bowel Disease: A Nicotine-Infection Interaction
Al-Qasrawi, D. S., Qasem, A., & Naser, S. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165801 · Cited by 22
“They also reported serious side effects such as headache, nausea, sleep disturbance, and acute pancreatitis [32].”
Background
Cholinergic anti-inflammatory pathway ameliorates murine experimental Th2-type colitis by suppressing the migration of plasmacytoid dendritic cells
Kanauchi, Y., Yamamoto, T., Yoshida, M., Zhang, Y., Lee, J., Hayashi, S., & Kadowaki, M. (2022) · Scientific Reports · doi:10.1038/s41598-021-04154-2 · Cited by 22
Alpha7-nicotinic acetylcholine receptors involve the imidacloprid-induced inhibition of IgE-mediated rat and human mast cell activation
Shi, L., Xu, H., Wu, Y., Li, X., Zou, L., Gao, J., & Chen, H. (2017) · RSC Advances · doi:10.1039/c7ra07862e · Cited by 22
Effects of transdermal nicotine treatment on structure and function of coronary artery bypass grafts
Clouse, W. D., Yamaguchi, H., Phillips, M. R., Hurt, R. D., Fitzpatrick, L. A., Moyer, T. P., Rowland, C. C., Schaff, H. V., & Miller, V. M. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.3.1213 · Cited by 22
“Nicotine is being used clinically to treat non-smoking-related disorders such as ulcerative colitis, Parkinson’s disease, Alzheimer’s disease, and sleep disorders (12, 14, 37, 39, 41).”
BackgroundResult
The Profit Motive and Spine Surgery
Weiner, B. K., & Levi, B. H. (2004) · Spine · doi:10.1097/01.brs.0000145505.84077.13 · Cited by 22
Nicotine Enemas for Active Crohn's Colitis: An Open Pilot Study
Ingram, J. R., Rhodes, J., Evans, B. K., & Thomas, G. A. O. (2008) · Gastroenterology Research and Practice · doi:10.1155/2008/237185 · Cited by 21
“A recent Cochrane Review [12] has confirmed benefit from transdermal nicotine in active UC: a meta-analysis of two eligible randomized placebo-controlled trials [13, 14] so far performed showed that after 4 to 6 weeks treatment, 19 of 71 patients treated with transdermal nicotine were in remission compared to 9 of 70…”
BackgroundSelf-citation
Literature-related discovery: common factors for Parkinson’s Disease and Crohn’s Disease
Kostoff, R. N. (2014) · Scientometrics · doi:10.1007/s11192-014-1298-3 · Cited by 21
Successful Treatment of Pyoderma Gangreno‐sum with Nicotine Chewing Gum
Kanekura, T., & Kanzaki, T. (1995) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1995.tb03904.x · Cited by 21
Monthly Updates: Monthly Update Central & Peripheral Nervous Systems: Beyond the tobacco debate: Dissecting out the therapeutic potential of nicotine
Williams, M. J., & Arnerić, S. P. (1996) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.5.8.1035 · Cited by 21
The benefits of smoking in skin diseases
Wolf, R. (1998) · Clinics in Dermatology · doi:10.1016/s0738-081x(98)00050-9 · Cited by 21
Neuroimmune communication of the cholinergic system in gut inflammation and autoimmunity
Halder, N., Yadav, S., & Lal, G. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103678 · Cited by 21
Dermatological Formulation and Transdermal Systems
Walters, K., & Brain, K. (2002) · Drugs and the pharmaceutical sciences · doi:10.1201/9780824743239.ch7 · Cited by 20
Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-Anal Anastomosis
Gorrepati, V. S., Stuart, A., Deiling, S. M., Koltun, W. A., Tinsley, A., Williams, E., & Coates, M. D. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy097 · Cited by 20
Effects of Nicotine on Angiogenesis and Restenosis in a Rabbit Model
Ruixing, Y., Qi, B., Tangwei, L., & Li, J. (2006) · Cardiology · doi:10.1159/000094658 · Cited by 20
“In addition, nicotine has been applied to the treatment of patients suffering from recurrent aphthous ulcers or active ulcerative colitis [ ,”
Background
The pathogenesis of Crohn's disease in the 21st century.
Hume, G. E., & Radford‐Smith, G. L. (2002) · PubMed · Cited by 20
Inflammatory Bowel Disease in the Elderly
Akerkar, G. A., & Peppercorn, M. A. (1997) · Drugs & Aging · doi:10.2165/00002512-199710030-00004 · Cited by 20
Transdermal Nicotine Decreases Mucosal IL-8 Expression but Has No Effect on Mucin Gene Expression in Ulcerative Colitis
Louvet, B., Buisine, M., Desreumaux, P., Tremaine, W. J., Aubert, J., Porchet, N., Capron, M., Cortot, A., Colombel, J., & Sandborn, W. J. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199908000-00005 · Cited by 20
Aktualisierte S3-Leitlinie Colitis ulcerosa
Kucharzik, T., Dignass, A., Atreya, R., Bokemeyer, B., Esters, P., Herrlinger, K., Kannengiesser, K., Kienle, P., Langhorst, J., Lügering, A., et al. (2019) · Zeitschrift für Gastroenterologie - German Journal of Gastroenterology · doi:10.1055/a-1015-7265 · Cited by 11
Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?
Leitzke, M. (2023) · Bioelectronic Medicine · doi:10.1186/s42234-023-00104-7 · Cited by 30
α7-nAChR-mediated suppression of hyperexcitability of colonic dorsal root ganglia neurons in experimental colitis
Abdrakhmanova, G. R., AlSharari, S. D., Kang, M., Damaj, M. I., & Akbarali, H. I. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00175.2010 · Cited by 19
“Controlled clinical trials using nicotine for treatment of ulcerative colitis have shown that the administration of a transdermal nicotine patch (21 mg/day) improved significantly the histological and global clinical score of colitis (5, 27, 30, 36).”
Background
THE MANAGEMENT OF ULCERATIVE COLITIS
Hanauer, S. B., & Baert, F. J. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.497 · Cited by 19
The Association Between Smoking and Inflammatory Bowel Disease Among Israeli Jewish Patients
Fich, A., Eliakim, R., Sperber, A. D., Carel, R. S., & Rachmilewitz, D. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030103 · Cited by 19
Successful treatment of digital ulceration in Buerger's disease with nicotine chewing gum
KAWABATA, KANEKURA, GUSHI, SHIMADA, HIGO, USUKI, & KANZAKI (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02643.x · Cited by 19
An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics
Green, Evans, Rhodes, Thomas, Ranshaw, Feyerabend, & Russell (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00057.x · Cited by 19
A Case-Control Study to Examine the Influence of Maternal Perinatal Behaviors on the Incidence of Crohnʼs Disease
Gruber, M., Marshall, J. R., Zielezny, M. A., & Lance, P. (1996) · Gastroenterology Nursing · doi:10.1097/00001610-199603000-00003 · Cited by 19
Parental smoking, type 1 diabetes, and islet autoantibody positivity in the offspring: A systematic review and meta‐analysis
Edstorp, J., Lampousi, A., & Carlsson, S. (2022) · Diabetic Medicine · doi:10.1111/dme.14830 · Cited by 20
Anatabine ameliorates intestinal inflammation and reduces the production of pro-inflammatory factors in a dextran sulfate sodium mouse model of colitis
Ruiz, P. A., Kogel, U., Sasso, G. L., Phillips, B. W., Sewer, A., Titz, B., Garcia, L., Kondylis, A., Guedj, E., Peric, D., et al. (2020) · Journal of Inflammation · doi:10.1186/s12950-020-00260-6 · Cited by 18
Successful treatment of orogenital ulceration with transdermal nicotine patches
Kanekura, T., & Kanzaki, T. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03226.x · Cited by 18
Recent Advances in Inflammatory Bowel Disease
Farrell, R. J., Banerjee, S., & Peppercorn, M. A. (2001) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/20014091084173 · Cited by 18
Mechanistic insight: Linking cardiovascular complications of inflammatory bowel disease
Kumarapperuma, H., Wang, R., Little, P. J., & Kamato, D. (2023) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2023.01.002 · Cited by 17
Complementary and alternative medicine and gastrointestinal diseases
Haas, L., McClain, C. J., & Varilek, G. W. (2000) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200003000-00016 · Cited by 17
The impact of smoking in Crohn's disease: no smoke without fire
Aldhous, M. C., & Satsangi, J. (2010) · Frontline Gastroenterology · doi:10.1136/fg.2010.001487 · Cited by 18
Role of Cholinergic Receptors in Colorectal Cancer: Potential Therapeutic Implications of Vagus Nerve Stimulation?
Pelissier-Rota, M., Lainé, M., Ducarouge, B., Bonaz, B., & Jacquier-Sarlin, M. (2013) · Journal of Cancer Therapy · doi:10.4236/jct.2013.46128 · Cited by 17
Drosophila as a Tool for Investigating the Molecular Genetics of Insecticide Resistance
ffrench‐Constant, R. H., Roush, R. T., & Cariño, F. A. (1993) · Springer series in experimental entomology · doi:10.1007/978-1-4613-9217-0_1 · Cited by 17
Current medical therapy for ulcerative colitis
Chang-tai, X. (1999) · World Journal of Gastroenterology · doi:10.3748/wjg.v5.i1.64 · Cited by 17
“Transdermal nicotine in doses of 15 mg - 25 mg daily added to conventional therapy was effective against placebo to control active disease [ 19 ].”
Ulcerative Colitis
Osterman, M. T., & Lichtenstein, G. R. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00112-8 · Cited by 17
The role of cigarettes and nicotine in the onset and treatment of ulcerative colitis
Birtwistle, J. (1996) · Postgraduate Medical Journal · doi:10.1136/pgmj.72.854.714 · Cited by 17
NEWER TREATMENTS FOR INFLAMMATORY BOWEL DISEASE
Stotland, B. R., & Lichtenstein, G. R. (1996) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70349-3 · Cited by 17
The clinical value of multimodal ultrasound for the evaluation of disease activity and complications in inflammatory bowel disease
Ma, C., Huang, P.-L., Kang, N., Zhang, J., Xiao, M., Zhang, J., Cao, X.-C., & Dai, X. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-2162 · Cited by 16
“After taking 2,000 mL polyethylene glycol electrolyte solution to clean the intestines, perform colonoscopy (Olympus, probe CF 260, Japan), and routinely take biopsy for histopathological evaluation (8,9).”
Method
The controversial effect of smoking and nicotine in SARS-CoV-2 infection
Salehi, Z., Gh, B. F. N. M., Nourian, Y. H., Jamalkandi, S. A., & Ghanei, M. (2023) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-023-00797-0 · Cited by 18
“While passive smoking is associated with an increased risk of intestinal surgeries in patients with CD [258], UC patients with a smoking history show improvements in their gut function after smoking, and tobacco cessation worsens their gut activity [170, 171, 259].”
Background
Nicotine replacement therapy as a treatment for complex aphthosis
Hill, S. C., Stavrakoglou, A., & Coutts, I. (2009) · Journal of Dermatological Treatment · doi:10.3109/09546630903271563 · Cited by 16

Authors: Pullan, R. D., Rhodes, J., Ganesh, S., Mani, V., Morris, J. S., Williams, G. T., Newcombe, R. G., Russell, M., Feyerabend, C., Thomas, G., & Sawe, U.
Affiliations: University Hospital of Wales (GB)
University of Wales (GB)
Princess of Wales Hospital (GB)
New Cross Hospital (GB)
ORCID: Newcombe, Robert G.
Thomas, Gareth
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1994-03-24
Volume: 330
Issue: 12
Pages: 811-815
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199403243301202
OpenAlex: W2315418290
Cited by: 505
References: 28
Citations by year: 2026: 3 · 2025: 6 · 2024: 9 · 2023: 11 · 2022: 10 · 2021: 10 · 2020: 20 · 2019: 9 · 2018: 14 · 2017: 7 · 2016: 5 · 2015: 11 · 2014: 14 · 2013: 15 · 2012: 9
FWCI: 15.58
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
Keywords: ulcerative colitis, transdermal nicotine, nicotine patch, smoking, nicotine withdrawal, 5-aminosalicylic acid, maintenance therapy, remission, symptom improvement, adverse effects
MeSH terms: Administration, Cutaneous, Adult, Affect, Colitis, Ulcerative, Cotinine, Double-Blind Method, Female, Humans, Male, Middle Aged, Nicotine, Treatment Outcome, Drug Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Transdermal Nicotine for Active Ulcerative Colitis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks